Virtual Medicinal Product (VMP)
-
Galsulfase 5mg/5ml solution for infusion vials
Name Details
Current Name
Galsulfase 5mg/5ml solution for infusion vials
|
Start Date
19-01-2009
|
End Date
|
Previous Name
Galsulfase 5mg/5ml solution for injection vials
|
Start Date
22-02-2006
|
End Date
18-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A16AB08
BNF |
Current BNF
09080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
09080100
|
Start Date
04-12-2007
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36061811000001100 |
30-10-2018 |
|
419538005 |
01-11-2006 |
29-10-2018 |
10097011000001107 |
22-02-2006 |
31-10-2006 |
VMP Ingredients
VMP ingredients table
Galsulfase |
Based on Ingredient Substance |
|
1 mg |
1 ml |
Name
Galsulfase
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Galsulfase
-
VMP
(Current) Galsulfase 5mg/5ml solution for infu...
Virtual Medicinal Product Pack (VMPP) Information